Treatment of klebsiella pneumoniae with liposomally formulated glutathione

{
  "publication_number": "US2015366933A1",
  "country": "US",
  "kind": "A1",
  "title": "Treatment of klebsiella pneumoniae with liposomally formulated glutathione",
  "abstract": "The composition of the invention, liposomal glutathione, has been recently shown to have utility for having an antibiotic like effect on Klebsiella pneumonia cultures in vitro, and in vivo as demonstrated by efficacy in reducing by large multiples the presence of cultures of Klebsiella in rats in animal tests. Further, because the liposomal glutathione bolsters body defenses as well as appearing to have direct killing action, the propensity to create more and more resistant strains to antibiotic treatment is downgraded.",
  "claims": [
    "1. A pharmaceutical composition comprising liposomally formulated reduced glutathione for use in the treatment of a mammalian patient suffering from pneumonia, particularly caused by an infection of Klebsiella pneumoniae. 2. The pharmaceutical composition of claim 1 wherein the reduced glutathione is included inside the liposome in an amount of at least 3.3% w/w. 3. A method of treatment of a mammalian patient having Klebsiella Pneumoniae comprising: administering liposomally formulated glutathione wherein the reduced glutathione included inside the liposome is in an amount of at least 3.3% w/w."
  ],
  "cpc": [
    "A61K 38/063",
    "A61K 9/0014",
    "A61K 9/0019",
    "A61K 9/0053",
    "A61K 9/006",
    "A61K 9/0095",
    "A61K 9/127",
    "A61K 9/4858",
    "A61P 31/04"
  ],
  "assignees": [
    "UNIV EMORY",
    "YOUR ENERGY SYSTEMS LLC",
    "CHILDRENS HEALTHCARE ATLANTA INC"
  ],
  "filing_date": "2014-02-14",
  "publication_date": "2015-12-24",
  "priority_date": "2013-02-15",
  "application_number": "US-201414767985-A",
  "family_id": "51351345",
  "citations": [
    "US2006099244A1",
    "US2010069309A1"
  ]
}